Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry
Crossref DOI link: https://doi.org/10.1007/s10067-016-3528-y
Published Online: 2017-01-05
Published Print: 2017-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Monti, Sara
Klersy, Catherine
Gorla, Roberto
Sarzi-Puttini, Piercarlo
Atzeni, Fabiola
Pellerito, Raffaele
Fusaro, Enrico
Paolazzi, Giuseppe
Rocchetta, Pier Andrea
Favalli, Ennio Giulio
Marchesoni, Antonio
Caporali, Roberto
License valid from 2017-01-05